2022 annual financial data
REGENXBIO 2022 Net margin
Direct answer
Net margin was -248.68%.
Operating income was -262,876,000 USD and net income was -280,321,000 USD.
Operating cash flow was -207,488,000 USD.
Get free REGENXBIO email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 112,724,000 USD
- Operating income
- -262,876,000 USD
- Net income
- -280,321,000 USD
- Operating cash flow
- -207,488,000 USD